
GLP-1 Hair Loss and Telogen Effluvium: Why It Happens and When Hair Grows Back
Hair loss on GLP-1 medications is usually telogen effluvium from rapid weight loss, not the drug itselfâmost people see regrowth within 6-12 months.
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition.
Your Hair Is Probably Not Falling Out Because of the Injection
Many people notice more hair in the shower drain a few months after starting a GLP-1 medication, often just as the weight loss is going well. The most likely explanation is usually not the drug in the pen itself but the rapid weight loss. Hair shedding is a well-known consequence of fast weight loss from any cause, including bariatric surgery, and the U.S. labels for semaglutide and tirzepatide both note that the hair loss reported in trials was associated with weight reduction.
What Telogen Effluvium Actually Means for Your Scalp
Your hair follicles are dramatic. They don't just grow continuouslyâthey cycle through phases like moody teenagers. The growth phase (anagen) lasts 2-7 years. Then comes a brief transition (catagen), followed by a resting phase (telogen) that typically affects about 10% of your hair at any given time.
Telogen effluvium happens when your body experiences a significant stressor and essentially hits the panic button. Suddenly, 30% or more of your follicles decide to take an early vacation, shifting from growth to rest simultaneously. Two to four months later, all that resting hair falls out at once.
That delay explains the typical timing: shedding usually shows up about two to three months after the trigger, which is why it often appears around the third or fourth month of treatment. Rapid caloric restriction signals to your body that resources are scarce, and hair, lovely as it is, isn't essential for survival. Your body triages.
GLP-1 Medications vs. Weight Loss: Separating the Variables
In the U.S. prescribing information for Wegovy (semaglutide 2.4 mg), hair loss was reported in 3.3% of treated adults versus 1% on placebo, more often in women. For Zepbound (tirzepatide), hair loss was reported in 4â5% versus 1% on placebo, again mostly in women (7.1% versus 0.5% of men). For comparison, an updated 2025 meta-analysis of 41 studies (7,044 patients) found hair loss in about 47% of people after bariatric surgery, a setting with very rapid weight loss.
Head-to-head data are limited. A 2025 retrospective database study in the Journal of the American Academy of Dermatology reported a higher risk of telogen effluvium with tirzepatide than with other weight-loss medications, while a 2025 systematic review described the overall evidence on GLP-1 drugs and hair loss as conflicting. Observational studies like these cannot fully separate the drug from the speed and amount of weight lost.
That said, we can't completely exonerate the medications. Some researchers hypothesize that GLP-1 receptor activity might influence hair follicle cycling directly, though this remains theoretical. Animal studies have found GLP-1 receptors in skin tissue, but human data on direct follicular effects is still sparse.
The Timeline: When Hair Falls and When It Returns
If you're currently watching your hair circle the drain, you probably want specifics. Fair enough.
Weeks 1-10 after starting GLP-1: Hair appears normal. The follicles haven't received the stress signal yet, or they're still in the growth phase.
Weeks 10-16: Shedding often becomes noticeable. Losing clearly more than the usual 50-100 hairs a day is typical of telogen effluvium. This is the phase that sends people spiraling into Reddit threads at midnight.
Months 4-6: Shedding often stabilizes. The follicles that were going to shift into telogen have done so. New growth begins at the scalp level, though it's not visible yet.
Months 6-12: Visible regrowth for most people. Those tiny baby hairs around your hairline? That's recovery in action.
Months 12-18: For most people, density gradually returns once the trigger settles; acute telogen effluvium is generally self-limiting. Shedding that continues beyond about six months is considered chronic and is worth having evaluated.
The frustrating truth: hair grows slowly. About half an inch per month. Even after follicles restart their growth phase, it takes time for that growth to become visible length.
Nutritional Factors That Accelerate (or Sabotage) Recovery
Your follicles need raw materials. When you're eating 1,200 calories daily and your appetite has vanished, certain nutrients often fall short.
Protein matters most. Hair is made largely of keratin, a protein, and protein deficiency is a recognized cause of shedding. There is no hair-specific protein target, but reviews on diet and hair loss stress adequate protein intake, which can be hard to reach when appetite is suppressed. Planning protein into every meal is a practical safeguard.
Iron is the second nutrient worth checking. Iron deficiency has been linked to hair loss in several studies, though the evidence is mixed and there is no agreed ferritin cutoff for hair. Menstruating women on GLP-1 medications are particularly vulnerable, since they're often eating less while still losing iron monthly.
Zinc and biotin get a lot of attention in hair supplement marketing, but the evidence is weaker. Zinc deficiency can contribute to hair loss, but supplementing when you're not deficient doesn't accelerate growth. Biotin deficiency is rare in people eating any reasonable diet; those 10,000 mcg supplements are mostly creating expensive urine.
The practical approach: prioritize protein at every meal, consider iron testing if shedding persists beyond 6 months, and don't waste money on hair gummies promising miracles.
Management Strategies That Actually Have Evidence
Let's be honest about what works and what's wishful thinking.
Slowing the rate of weight loss addresses the main trigger, though no trial has tested this specifically for GLP-1-related shedding. If shedding is distressing, it is reasonable to ask your prescriber whether your titration pace is right for you.
Topical minoxidil is sometimes used for telogen effluvium, though it's not FDA-approved for this indication and the evidence is limited. It's hard to separate any benefit from the natural recovery that usually occurs anyway.
Low-level laser therapy (LLLT) devices are another option, but most of the evidence comes from androgenetic alopecia rather than telogen effluvium. These devices aren't cheap, which makes the cost-benefit calculation personal.
Platelet-rich plasma (PRP) injections are increasingly offered by dermatologists. The theory is soundâgrowth factors concentrated from your own blood might stimulate folliclesâbut the evidence for telogen effluvium specifically is limited. Most PRP research focuses on androgenetic alopecia, a different condition.
What doesn't work: panic-stopping your GLP-1 medication. The shedding you're seeing now reflects a stress signal from months ago. Stopping the medication won't reverse hair that's already in telogen; it'll just potentially restart the weight gain cycle.
When to Actually Worry: Red Flags Beyond Normal Shedding
Not all hair loss during GLP-1 treatment is benign telogen effluvium. Some patterns warrant dermatology evaluation.
Patchy loss rather than diffuse thinning suggests alopecia areata, an autoimmune condition that requires different treatment.
Scalp symptoms like itching, burning, scaling, or visible inflammation point toward other conditionsâseborrheic dermatitis, psoriasis, or scarring alopecias that can cause permanent damage if untreated.
Shedding lasting beyond 6 months without any sign of regrowth deserves investigation. Chronic telogen effluvium exists but is uncommon; persistent shedding might indicate an underlying thyroid disorder, iron deficiency anemia, or other medical issue that the weight loss unmasked.
Visible scalp through hair that wasn't there before, especially in a pattern (temples, crown), might suggest androgenetic alopecia becoming more apparent as overall hair volume decreases. This is a separate condition that won't resolve on its own.
A dermatologist can perform a pull test, examine your scalp under magnification, and order bloodwork to rule out contributing factors. This isn't about being dramaticâit's about catching treatable conditions early.
The Psychological Weight of Watching Your Hair Fall Out
Here's something the clinical literature often ignores: losing your hair while trying to improve your health feels like a cruel joke. You finally found something that helps with weight management, and now you're trading one source of distress for another.
That emotional response is valid. Hair is tied to identity, femininity, masculinity, youth, health. Watching it fall outâeven temporarilyâcan trigger grief, anxiety, and serious second-guessing about whether this medication is worth it.
Some perspective that might help: the shedding is almost always temporary. The weight loss benefits, if maintained, are lasting. And for most people, the hair does come back. Not immediately, not dramatically, but steadily.
If the anxiety is significant, talking to your prescriber about adjusting the titration schedule is reasonable. So is connecting with others going through the same experienceâonline communities for GLP-1 users are full of before-and-after photos showing recovery. Sometimes seeing that others emerged on the other side makes the waiting more bearable.
đ Key Stats
Reported Hair Loss Rates by Weight Loss Method
| Weight Loss Method | Reported Hair Loss Rate | Source |
|---|---|---|
| Semaglutide 2.4 mg (Wegovy) | 3.3% vs 1% on placebo | U.S. prescribing information |
| Tirzepatide (Zepbound) | 4â5% vs 1% on placebo | U.S. prescribing information |
| Bariatric surgery | About 47% (pooled) | Meta-analysis, 2025 |
| Diet-only calorie restriction | Not well quantified | â |
Rates come from different study types and are not directly comparable; both drug labels note that hair loss was associated with weight reduction
â Frequently Asked Questions
Is hair loss from Ozempic or Wegovy permanent?
Should I stop taking my GLP-1 medication if I'm losing hair?
How much hair loss is normal on GLP-1 medications?
Do hair supplements help with GLP-1-related hair loss?
Does minoxidil work for telogen effluvium from weight loss?
Why does hair loss start 3 months after beginning GLP-1 treatment?
Is hair loss more common with tirzepatide or semaglutide?
What is HAVIT?
HAVIT is an AI health partner built on metabolic science â it protects your muscle, wakes up your metabolism, and helps you keep a healthy, rebound-free body for the long run.
Unlike calorie-only trackers, HAVIT connects AI body-composition estimates, nutrition, hydration, sleep, steps, cycle, mood, and GLP-1 medication in one daily routine â so progress is measured by body composition, not just the number on the scale. Daily missions turn established behavior-change techniques into small repeatable actions, drawing on expertise from professionals formerly at Juvis Diet, one of Koreaâs leading metabolic clinics.
In HAVITâs own analysis of 1,090 GLP-1 users, people who logged consistently built stronger habits than the general user base. Read the GLP-1 Habit Report
Inside the app
- AI COACHA coach that reads your day.
- NUTRITIONLog meals in seconds.
- BODY INSIGHTSSee more than weight.
- DAILY MISSIONSBuild habits you can repeat.
- DAILY CHECK-INTell HAVI how today feels.
- TRACK EVERYTHINGFrom water to GLP-1
- MIND & RECOVERYFor the days willpower runs out.
HAVIT works with or without GLP-1 medication. It is a wellness app, not a medical device; body-composition results are estimates.
References
- Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study â Journal of the American Academy of Dermatology, 2025
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review â Cureus, 2025
- Hair Loss and Metabolic and Bariatric Surgery: An Updated Systematic Review and Meta-analysis â Obesity Surgery, 2025
- Telogen Effluvium: A Review of the Literature â Cureus, 2020
- Diet and hair loss: effects of nutrient deficiency and supplement use â Dermatology Practical & Conceptual, 2017
- Nutritional factors and hair loss â Clinical and Experimental Dermatology, 2002
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) â New England Journal of Medicine, 2021
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) â New England Journal of Medicine, 2022
- WEGOVY (semaglutide) injection â Prescribing Information â Novo Nordisk (U.S. FDA-approved labeling), 2026
- ZEPBOUND (tirzepatide) injection, for subcutaneous use: Prescribing Information â U.S. FDA, 2025















